Please ensure Javascript is enabled for purposes of website accessibility

What More Can You Ask of Walgreen?

By Andrew Bond – Updated Apr 6, 2017 at 10:47PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Post-earnings sell-off provides buying opportunity.

Tuesday's sell-off in shares of Walgreen (NYSE: WAG) provides a buying opportunity for investors who want in on a best-of-breed company at a discount. While Walgreen's second quarter wasn't as good as its most recent quarters, the biggest problem I saw was that analysts' expectations were a bit too high since the company had been performing so well as of late.

Profit rose 10% and sales rose close to 9% in the quarter, outpacing consensus estimates, while Walgreen also continues to gain market share in the retail prescription business, but the whisper numbers had investors looking for even better results. The company has outperformed competitors such as CVS (NYSE: CVS) and Rite Aid (NYSE: RAD) by focusing on cost-cutting throughout its stores and slowing its rapid expansion to focus on same-store-sales growth, which continues to improve.  Walgreen has used some of these cost savings to reward shareholders through share buybacks and dividends. The company bought $300 million in shares in the quarter and $500 million in the first quarter.

The company has made some savvy moves of late to separate itself from competitors. Walgreen earlier this month ridded itself of its pharmacy benefit management business, which didn't quite fit within the company's core strategy and, as CEO Greg Wasson said, created "conflicts" within the business. CVS has also struggled significantly with its PBM business integration of Caremark, and a similar move might be in order for that company as well.

I am also impressed with Walgreen's focus on tailoring specific stores to individual communities. Walgreen has been particularly strong in this regard with its highly successful acquisition of New York City drug chain Duane Reade. In a place like Williamsburg, N.Y., which is perhaps the hipster capital of the U.S., this is essential for success.  In this small community in Brooklyn, change and big corporate brands are not readily accepted, and Walgreen faced local protests to prevent the company from opening a new Duane Reade store near the local mom-and-pop drugstore.

To appease the community, Walgreen decided to differentiate itself from the longtime community drug store by adding draft beer lines in which customers could fill growlers to take home. The store also focuses on local breweries from the region, such as Sixpoint Craft Ales and Brooklyn Brewery, both of which operate just a few miles away. While hipsters may not like corporate chains, they certainly like beer.

Walgreen is still outperforming its competitors, and management continues to prove adept in following its strategy of focusing on store quality over quantity.  I believe yesterday's sell-off is a good opportunity to get in on this best-of-breed company that continues to perform.

Andrew Bond owns no shares in the companies listed. You can follow Andrew on Twitter @Bond0 or on his RSS feed. Try any of our Foolish newsletter services free for 30 days. The Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
WBA
$32.69 (-0.43%) $0.14
CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$97.74 (-0.62%) $0.61
Rite Aid Corporation Stock Quote
Rite Aid Corporation
RAD
$6.50 (-7.28%) $0.51

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.